Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy

Abstract The hepatitis B virus (HBV) infection continues to pose its own share of health challenges in the world with almost 296 million infected and over 820,000 liver related deaths happening every year. The existing drugs such as nucleoside analogues and interferon-alpha can suppress the replicat...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Samuel Chima Ugbaja, Reuben Samson Dangana, Idris Olatunji Sanusi, Olukayode Adebola Ibitoye, Asekho Nkungu, Lwandiswa Mafuleka, Moses Okpeku, Nceba Gqaleni
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Springer 2026-04-01
श्रृंखला:	Discover Artificial Intelligence
विषय:	Artificial intelligence Machine learning Drug repurposing Hepatitis B virus Virtual screening
ऑनलाइन पहुंच:	https://doi.org/10.1007/s44163-026-01263-7
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!